Mangoceuticals (MGRX) Cash from Operations Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Cash from Operations Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.29 Bn | 24.98 Bn | 662.02 Mn | 28.50% |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | 21.01% |
| 3 | Healthequity | 8.43 Bn | 8.16 Bn | 256.31 Mn | 50.65% |
| 4 | Hinge Health | 5.96 Bn | 5.65 Bn | 154.23 Mn | 774.78% |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -23.96% |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | -304.82% |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | 32.16% |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 11.20% |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - | -105.58% |
| 10 | Mangoceuticals | 8.91 Mn | 8.72 Mn | 29,001.00 | 42.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.35% |
| Dec 31, 2025 | 4.59% |
| Sep 30, 2025 | -6.47% |
| Jun 30, 2025 | 20.34% |
| Mar 31, 2025 | -129.51% |
| Dec 31, 2024 | 33.47% |
| Sep 30, 2024 | 31.85% |
| Jun 30, 2024 | 11.42% |
| Mar 31, 2024 | 45.19% |